Requesting data from Hartwig Medical Foundation is now easier
As of September 1, 2026, the procedure for requesting data from the Hartwig Medical Database has been simplified. With this change, we aim to make it easier for researchers to submit a data access request.
A simpler request procedure
For new data requests, the existing License Agreement has been replaced by new General Terms & Conditions.
This new request procedure aligns with the mission of Hartwig Medical Foundation: improving care for patients with cancer. Hartwig collects patients’ genetic and clinical data securely and in coded form in the Hartwig Medical Database and makes it available for scientific research as effectively and quickly as possible. In this way, Hartwig contributes to knowledge about cancer and how to treat the disease.
Researchers thus work together to develop new and effective cancer treatments. In addition, a number of related documents have been updated.
Together with the Guiding Principles, the Rules of Procedure for Data Access Requests, and the Publication Policy, the General Terms & Conditions form the framework within which researchers gain access to data from the Hartwig Medical Database. Furthermore, it is now also easier for researchers to reference the data, thanks to the introduction of so-called DOIs.
What does this mean for you as a researcher?
The updated procedure applies to all new data requests as of September 1, 2026. The request process has been simplified and is intended to contribute to shorter turnaround times. In this way, we aim to make it easier for researchers to gain access to the data they need for scientific research.
Access to Hartwig data remains based on patient consent and is intended for scientific research and healthcare improvement in public interest.
New data requests only
The change applies exclusively to new data requests; existing License Agreements remain in effect.
View the updated documents
The complete set of documents is available on the Hartwig Medical Foundation website. If you have
questions about the new General Terms & Conditions or what they mean for a current or future data
request, please contact us at dataaccess@hartwigmedicalfoundation.nl.
All news
Also read
Whole Genome Sequencing feasible in clinical practice
Interim WIDE analysis gives researchers more confidence in a positive outcome. On 21 September 2020, Dr. Kim Monkhorst, who is a …
The Role of organoids and Whole Genome Sequencing in precision oncology
Organoids can help determine which patients with metastatic colorectal cancer (mCRC) are likely to respond to chemotherapy and which targeted …
The Importance of Analyzing the DNA of Rare Tumors
One in four patients has a cancer type that is considered rare, meaning it occurs in fewer than six out …
The fact that the CPCT, together with Hartwig Medical Foundation, has managed to bundle data, knowledge and expertise from almost all Dutch hospitals is unique and now also deserves international attention.